• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症的神经病理学:新概念

Neuropathology in multiple sclerosis: new concepts.

作者信息

Lassmann H

机构信息

Institute of Neurology, University of Vienna, Austria.

出版信息

Mult Scler. 1998 Jun;4(3):93-8. doi: 10.1177/135245859800400301.

DOI:10.1177/135245859800400301
PMID:9762654
Abstract

Multiple sclerosis lesions are characterized by inflammation, demyelination and a variable degree of axonal loss. The patterns of inflammation in MS lesions are compatible with a T-lymphocyte mediated immune reaction. The formation of demyelinated plaques, however, seem to require additional immunological mechanisms. In this review evidence is discussed for a pathogenetic role of demyelinating antibodies, toxic macrophage products, cytotoxic T-cells as well as metabolic disturbances of oligodendrocytes. It is suggested that the pathological heterogeneity regarding the patterns and extent of demyelination, remyelination and axonal loss may be the outcome of variable dominant immunopathogenetic mechanisms in different multiple sclerosis patients.

摘要

多发性硬化症病变的特征是炎症、脱髓鞘以及不同程度的轴突损失。多发性硬化症病变中的炎症模式与T淋巴细胞介导的免疫反应相符。然而,脱髓鞘斑块的形成似乎需要额外的免疫机制。在这篇综述中,我们讨论了脱髓鞘抗体、毒性巨噬细胞产物、细胞毒性T细胞以及少突胶质细胞代谢紊乱在发病机制中的作用证据。有人提出,脱髓鞘、再髓鞘化和轴突损失的模式和程度方面的病理异质性可能是不同多发性硬化症患者中不同主导免疫发病机制的结果。

相似文献

1
Neuropathology in multiple sclerosis: new concepts.多发性硬化症的神经病理学:新概念
Mult Scler. 1998 Jun;4(3):93-8. doi: 10.1177/135245859800400301.
2
Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation.多发性硬化症中的急性轴突损伤。与脱髓鞘和炎症的相关性。
Brain. 2000 Jun;123 ( Pt 6):1174-83. doi: 10.1093/brain/123.6.1174.
3
Patterns of oligodendroglia pathology in multiple sclerosis.多发性硬化症中少突胶质细胞病理学模式
Brain. 1994 Dec;117 ( Pt 6):1311-22. doi: 10.1093/brain/117.6.1311.
4
Neuropathology of multiple sclerosis-new concepts.多发性硬化症的神经病理学——新概念
Brain Res Bull. 2003 Aug 15;61(3):321-6. doi: 10.1016/s0361-9230(03)00095-9.
5
[Pathogenesis of multiple sclerosis and other neural autoimmune diseases].[多发性硬化症及其他神经自身免疫性疾病的发病机制]
Verh Dtsch Ges Pathol. 1996;80:109-15.
6
Oligodendrocytes in the early course of multiple sclerosis.多发性硬化早期的少突胶质细胞。
Ann Neurol. 1994 Jan;35(1):65-73. doi: 10.1002/ana.410350111.
7
Histopathology and the blood-cerebrospinal fluid barrier in multiple sclerosis.多发性硬化症中的组织病理学与血脑脊髓液屏障
Ann Neurol. 1994;36 Suppl:S42-6. doi: 10.1002/ana.410360713.
8
Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.多发性硬化症病变的异质性:对脱髓鞘发病机制的影响。
Ann Neurol. 2000 Jun;47(6):707-17. doi: 10.1002/1531-8249(200006)47:6<707::aid-ana3>3.0.co;2-q.
9
Remyelinating strategies in multiple sclerosis.多发性硬化症中的再髓鞘化策略。
Expert Rev Neurother. 2014 Nov;14(11):1315-34. doi: 10.1586/14737175.2014.969241.
10
Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination.多发性硬化症:抗体和补体介导的脱髓鞘的原位证据。
Ann Neurol. 1998 Apr;43(4):465-71. doi: 10.1002/ana.410430409.

引用本文的文献

1
The Therapeutic Potential and Molecular Mechanisms Underlying the Neuroprotective Effects of Sativex - A Cannabis-derived Spray.欣百达(盐酸度洛西汀肠溶胶囊)治疗纤维肌痛的有效性和安全性:一项为期 12 周、随机、双盲、安慰剂对照研究
Mini Rev Med Chem. 2024;24(15):1427-1448. doi: 10.2174/0113895575285934240123110158.
2
Chronic experimental autoimmune encephalomyelitis is an excellent model to study neuroaxonal degeneration in multiple sclerosis.慢性实验性自身免疫性脑脊髓炎是研究多发性硬化症中神经轴突退变的极佳模型。
Front Mol Neurosci. 2022 Oct 19;15:1024058. doi: 10.3389/fnmol.2022.1024058. eCollection 2022.
3
A Critical Review of the Role of the Cannabinoid Compounds Δ-Tetrahydrocannabinol (Δ-THC) and Cannabidiol (CBD) and their Combination in Multiple Sclerosis Treatment.
大麻素化合物 Δ-四氢大麻酚(Δ-THC)和大麻二酚(CBD)及其联合在多发性硬化症治疗中的作用的批判性评价。
Molecules. 2020 Oct 25;25(21):4930. doi: 10.3390/molecules25214930.
4
Immune-mediated genesis of multiple sclerosis.多发性硬化症的免疫介导发病机制。
J Transl Autoimmun. 2020 Jan 28;3:100039. doi: 10.1016/j.jtauto.2020.100039. eCollection 2020.
5
Friend, Foe or Both? Immune Activity in Alzheimer's Disease.朋友、敌人还是兼而有之?阿尔茨海默病中的免疫活动。
Front Aging Neurosci. 2019 Dec 10;11:337. doi: 10.3389/fnagi.2019.00337. eCollection 2019.
6
TMEM10 Promotes Oligodendrocyte Differentiation and is Expressed by Oligodendrocytes in Human Remyelinating Multiple Sclerosis Plaques.TMEM10 促进少突胶质细胞分化,并在人类多发性硬化症再髓鞘斑块中的少突胶质细胞中表达。
Sci Rep. 2019 Mar 5;9(1):3606. doi: 10.1038/s41598-019-40342-x.
7
Clinical pharmacology of alemtuzumab, an anti-CD52 immunomodulator, in multiple sclerosis.阿仑单抗的临床药理学:一种抗 CD52 免疫调节剂在多发性硬化症中的应用。
Clin Exp Immunol. 2018 Dec;194(3):295-314. doi: 10.1111/cei.13208. Epub 2018 Oct 1.
8
Fractional anisotropy of white matter, disability and blood iron parameters in multiple sclerosis.多发性硬化症患者的脑白质各向异性分数、残疾程度与血液铁参数。
Metab Brain Dis. 2018 Apr;33(2):545-557. doi: 10.1007/s11011-017-0171-5. Epub 2018 Feb 2.
9
Axonal loss in the multiple sclerosis spinal cord revisited.再探多发性硬化症脊髓中的轴突损失
Brain Pathol. 2018 May;28(3):334-348. doi: 10.1111/bpa.12516. Epub 2017 May 7.
10
Cytokine and chemokine alterations in tissue, CSF, and plasma in early presymptomatic phase of experimental allergic encephalomyelitis (EAE), in a rat model of multiple sclerosis.在多发性硬化症大鼠模型实验性自身免疫性脑脊髓炎(EAE)的早期症状前阶段,组织、脑脊液和血浆中的细胞因子和趋化因子变化
J Neuroinflammation. 2016 Nov 15;13(1):291. doi: 10.1186/s12974-016-0757-6.